Merck (MRK) Non-Current Debt (2016 - 2025)
Historic Non-Current Debt for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $40.0 billion.
- Merck's Non-Current Debt rose 1425.59% to $40.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 billion, marking a year-over-year increase of 1425.59%. This contributed to the annual value of $34.5 billion for FY2024, which is 231.27% up from last year.
- Latest data reveals that Merck reported Non-Current Debt of $40.0 billion as of Q3 2025, which was up 1425.59% from $34.0 billion recorded in Q2 2025.
- Merck's Non-Current Debt's 5-year high stood at $40.0 billion during Q3 2025, with a 5-year trough of $22.9 billion in Q3 2021.
- For the 5-year period, Merck's Non-Current Debt averaged around $31.1 billion, with its median value being $31.1 billion (2024).
- Per our database at Business Quant, Merck's Non-Current Debt crashed by 1297.06% in 2021 and then skyrocketed by 2743.1% in 2022.
- Over the past 5 years, Merck's Non-Current Debt (Quarter) stood at $30.7 billion in 2021, then fell by 6.34% to $28.7 billion in 2022, then increased by 17.18% to $33.7 billion in 2023, then rose by 2.31% to $34.5 billion in 2024, then grew by 15.98% to $40.0 billion in 2025.
- Its Non-Current Debt was $40.0 billion in Q3 2025, compared to $34.0 billion in Q2 2025 and $33.5 billion in Q1 2025.